This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Pertussis Outbreaks Hit West, Midwest -- Again
Parents' Refusal to Vaccinate Singled Out as Contributor
By Matt Brown
This Gram-stained photomicrograph depicts numbers of Bordetella pertussis bacteria, the etiologic pathogen for pertussis.
Outbreaks of pertussis are again hitting multiple parts of the country, with Montana, Washington and Wisconsin all reporting significant increases in the number of cases of whooping cough.
As of May 19, for example, the Washington State Department of Health had reported a total of 1,738 cases throughout the state. By the same date in 2011, Washington had reported only 148 cases. The current figures put the state on track to have the highest number of reported cases in decades.
In April, Washington Secretary of Health Mary Selecky stated that pertussis had reached epidemic levels in the state, and she called for all eligible children and adults to be vaccinated against the disease. Specifically, she said that children ages 7-10 years who are not fully vaccinated should complete the diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine series, and those age 11 or older should receive a tetanus and diphtheria toxoids and acellular pertussis (Tdap) booster.
In April, Washington Secretary of Health Mary Selecky stated that pertussis had reached epidemic levels in the state, and she called for all eligible children and adults to be vaccinated against the disease. Specifically, she said that children ages 7-10 years who are not fully vaccinated should complete the diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine series, and those age 11 or older should receive a tetanus and diphtheria toxoids and acellular pertussis (Tdap) booster.
AAFP Signs On To Letter Denouncing Vaccine 'Myths,' 'Untruths'
The AAFP, in conjunction with the American Academy of Pediatrics, the AMA and other stakeholder organizations, recently sent a sharply worded letter of protest (2-page PDF; About PDFs)to the group president of Discovery Communications' two leading networks: Discovery Channel and TLC (formerly, The Learning Channel). In the letter, the organizations denounce an article titled "5 Things to Consider When Deciding to Vaccinate Your Child" that was published on the website of the Discovery Communications' wholly owned subsidiary, "HowStuffWorks."
The article raised a number of inaccurate concerns, such as claiming that people can "catch" the disease a vaccine is meant to prevent from the vaccine itself. The article's author also resurrected the long-debunked issue of a potential link between vaccines and autism and supported the idea of parents delaying their child's immunizations.
"Parents need accurate, complete information about immunizations -- which they often look for online," the letter said. "So we were astounded when we found an article on a Discovery Company website that perpetuates dangerous myths and untruths about vaccines. We cannot understand how a company that celebrates the latest in scientific achievements would feature an article so inaccurate and wholly biased against science."
The article was taken down soon after the letter was received.
The article raised a number of inaccurate concerns, such as claiming that people can "catch" the disease a vaccine is meant to prevent from the vaccine itself. The article's author also resurrected the long-debunked issue of a potential link between vaccines and autism and supported the idea of parents delaying their child's immunizations.
"Parents need accurate, complete information about immunizations -- which they often look for online," the letter said. "So we were astounded when we found an article on a Discovery Company website that perpetuates dangerous myths and untruths about vaccines. We cannot understand how a company that celebrates the latest in scientific achievements would feature an article so inaccurate and wholly biased against science."
The article was taken down soon after the letter was received.
Washington Gov. Chris Gregoire also got into the act, announcing in a May 3 news release that the state had received CDC approval to use federal funds designated for other immunizations to buy more than 27,000 doses of pertussis vaccine for uninsured and underinsured adults. In addition, she announced that the state would use $210,000 in existing health department funds, plus another $90,000 in emergency funds, "to strengthen public awareness efforts about the need for vaccination."
According to Michele Roberts, health promotion and communications section manager for the Washington State Department of Health Immunization and Child Profile Office, the state has one of the highest percentages of parents in the nation who choose to opt out of having their children immunized. In 2011, she said, roughly 6 percent of kindergartners in the state missed one of the required immunizations because a parent chose not to vaccinate.
According to Michele Roberts, health promotion and communications section manager for the Washington State Department of Health Immunization and Child Profile Office, the state has one of the highest percentages of parents in the nation who choose to opt out of having their children immunized. In 2011, she said, roughly 6 percent of kindergartners in the state missed one of the required immunizations because a parent chose not to vaccinate.
Long an outspoken advocate of immunization, the AAFP partnered with the CDC and American Academy of Pediatrics in 2010 to offer Provider Resources for Vaccine Conversations with Parents and, more recently, first-person parental accounts that detail the toll pertussis can take on infants. All are intended to help physicians reassure parents who have concerns about their child's vaccines.
In addition, the AAFP has adopted provisional recommendations for the use of Tdap vaccine that are consistent with those developed by the CDC's Advisory Committee on Immunization Practices (ACIP) and that are intended to stop the spread of disease to young patients who cannot yet receive the vaccine. Among those provisional recommendations are the following:
In addition, the AAFP has adopted provisional recommendations for the use of Tdap vaccine that are consistent with those developed by the CDC's Advisory Committee on Immunization Practices (ACIP) and that are intended to stop the spread of disease to young patients who cannot yet receive the vaccine. Among those provisional recommendations are the following:
- adults ages 19 and older who have not received a dose of Tdap vaccine should receive a single dose of the vaccine;
- Tdap vaccine should be administered regardless of the interval since administration of the last tetanus or diphtheria toxoid-containing vaccine; and
- adults should receive a Tdap dose if the dose is recommended and no record of previous administration exists.
The ACIP's provisional recommendations also account for the fact that two Tdap products are available in the U.S. market. They are GlaxoSmithKline's Boostrix, which is approved for use in people ages 10 years and older, and Sanofi Pasteur's Adacel, which is approved for use in patients, ages 11-64. Specifically, the recommendations state that
- vaccine providers should not miss an opportunity to vaccinate eligible patients ages 65 and older and may administer whatever vaccine they have available; and
- when feasible, Boostrix should be used for adults ages 65 and older, although either vaccine product administered to a person in this age group provides protection and is considered valid.
Share this on AAFP Connection
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Search AAFP News Now
Health of the Public
Though Waning, H7N9 Still Poses Pandemic Potential
AUA Says No to Routine PSA Screening
AAFP Criticizes Appeal of Plan B One-Step Ruling
AAFP to Hospitals: Stop Early Elective Deliveries
AAFP, USPSTF Differ Somewhat on HIV Screening Guidance
Zoledronic Acid Confers Both Pros, Cons
ACP Issues Guidance on PSA Screening
Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter
Discuss Drug Options With Women at Risk for Breast Cancer
Shingles Vaccine Effective, But Uptake Is Low
Evidence Lacking to Make Oral Cancer Screening Recommendation
Two External Guidelines Get Qualified AAFP Endorsement
USPSTF Recommends BRCA Testing for High-risk Women
Primary Care, Public Health Look for Ways to Integrate
Malfunction Prompts Glucose Meter Recall
Evidence Lacking on PAD Screening, Says USPSTF
Azithromycin Poses Arrhythmia Risk, Says FDA
Vets With PTSD Often Prescribed Inappropriate Meds
AIM-HI Offers Grants to Combat Childhood Obesity
USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures
PCV13, HibMenCY Vaccine Changes Approved by ACIP
AAFP, Other Groups Release More Choosing Wisely Lists
National Office Champions Tobacco Cessation Project Successful
USPSTF Issues Draft Statement on Glaucoma Screening
Study Examines Overuse, Inappropriate Use of Health Services
Apply to Become an AAFP Vaccine Science Fellow
Study Looks to Reduce PSA Screening Risks
AAP Issues New Clinical Guidance on Type 2 Diabetes
CDC: Adult Vaccination Rates Still Too Low
Pertussis Outbreaks Declining, but Immunization Still Key
2013 Immunization Schedules Include Several Changes
FDA Warns of Liver Injury Risk With Samsca Use
FDA Approves First Recombinant Trivalent Influenza Vaccine
AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence
Breast Cancer Screening in Older Women Costly, Likely Ineffective
CDC Gives Flu Update, Urges Continued Vaccination
Aerobic Exercise Beats Resistance Training for Weight Control